The new Communication Chemistry study from Silva's group at UFRJ and collaborators uses high-pressure NMR, fluorescence, and MD simulations to map p53's energetic frustration and defective hydrophobic gates, showing why it unfolds heterogeneously into aggregates unlike stable p63/p73 paralogs. This biophysical work (non-RCT, in vitro molecular scale with no human sample size or clinical endpoints) builds on the team's 20+ years of prior aggregation research but stops short of linking findings to population-level mutation spectra or therapy trials. What coverage misses is the deeper pattern across cancer genomics: p53 mutations cluster exactly in these frustrated regions, a vulnerability amplified by environmental stressors like hypoxia that the study only models indirectly. Synthesizing with Joerger et al. (Nature Reviews Cancer, 2023 observational review of 10,000+ tumors) and Xu et al. (Cell, 2022 MD simulation paper on paralog stability), the trade-off emerges as selection for transcriptional versatility in stress responses that inherently destabilizes the core domain. No conflicts declared in the primary work, though Silva holds related patents on p53 stabilizers. This reframes prevention toward early aggregate-clearing agents rather than late-stage gene replacement.